Advertisement
The Scientist
The Scientist

The Scientist

» clinical trials, immunology and neuroscience

Most Recent

image: Does Brain Training Work?

Does Brain Training Work?

By | April 21, 2014

Experts are skeptical about the effectiveness of games that claim to improve cognitive function. 

9 Comments

image: How Artistic Brains Differ

How Artistic Brains Differ

By | April 18, 2014

A study reveals structural differences between the brains of artists and non-artists.

3 Comments

image: Triggering Resilience to Depression

Triggering Resilience to Depression

By | April 17, 2014

In mice, boosting depression-causing activity in neurons can actually reverse depressive symptoms.

4 Comments

image: A Face to Remember

A Face to Remember

By | April 17, 2014

Researchers show that a tuning algorithm can make one’s profile photo more memorable.

5 Comments

image: Sex-Biased Alzheimer’s Variant

Sex-Biased Alzheimer’s Variant

By | April 14, 2014

Women with a notorious variant of a gene involved in Alzheimer’s, APOE4, are much more likely than men with the variant to develop the neurodegenerative disease.

0 Comments

image: Traces of Trauma in Sperm RNA

Traces of Trauma in Sperm RNA

By | April 13, 2014

A mouse study shows that molecular remnants of early-life stress can be passed on to future generations.

2 Comments

image: Opinion: Overcoming Cancer’s Complexities

Opinion: Overcoming Cancer’s Complexities

By , , and | April 11, 2014

Considering “targeted therapeutics” in the face of intra-patient heterogeneity. 

2 Comments

image: Updated Review: Tamiflu Is a Bust

Updated Review: Tamiflu Is a Bust

By | April 10, 2014

After finally getting their hands on full clinical study reports, independent reviewers say the antiviral drug is ineffective.

6 Comments

image: The Promise of Nanomedicine

The Promise of Nanomedicine

By | April 8, 2014

At AACR, scientists discuss the growing interest in nanotechnology and how it can be used to study, diagnose, and treat cancer.

0 Comments

image: Epigenetic Cancer Therapy Clears Phase I

Epigenetic Cancer Therapy Clears Phase I

By | April 7, 2014

Investigational drug that inhibits proteins involved with epigenetic regulation shows activity against certain blood cancers in an early-stage clinical trial.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
UVP
UVP
Advertisement